World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
75
Citations
20706
World Ranking
5297
National Ranking
407

Peter A. Kiener publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Peter A. Kiener sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 167 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Peter A. Kiener D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Peter A. Kiener sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 75 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Peter A. Kiener is affiliated with AstraZeneca in the United Kingdom. Their research primarily spans the fields of Immunology and Microbiology as well as Medicine.

The scientist's work encompasses several subfields, including Immunology, Oncology, and Genetics. Key topics in their research involve CAR-T cell therapy, immunotherapy and immune responses, virus-based gene therapy, and immune cell function and interaction.

Recent publications include:

  • "CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies" (2020) in Clinical Cancer Research
  • "Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells" (2021) in Scientific Reports

Frequent co-authors collaborating with Kiener include Steven N. Quayle, Dharma R. Thapa, Zohra Merazga, Paige Ruthardt, and Jonathan Soriano.

The venues where the scientist's work has most commonly appeared are Clinical Cancer Research and Scientific Reports.

Best Publications

  • Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE.

    Jane Tian;Ana Maria Avalos;Su-Yau Mao;Bo Chen

  • Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)

    William F. Dall'Acqua;Peter A. Kiener;Herren Wu

  • Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils.

    W C Liles;P A Kiener;J A Ledbetter;A Aruffo

  • MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function.

    Roland Kolbeck;Alexander Kozhich;Masamichi Koike;Li Peng

  • A Chitinase-like Protein in the Lung and Circulation of Patients with Severe Asthma

    Geoffrey L Chupp;Chun Geun Lee;Nizar Jarjour;Yun Michael Shim

  • Expression of functional CD40 by vascular endothelial cells.

    Diane Hollenbaugh;Nicole Mischel-Petty;Caroline P. Edwards;Jan C. Simon

  • Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract.

    Herren Wu;David S. Pfarr;Syd Johnson;Yambasu A. Brewah

  • Increasing the Affinity of a Human IgG1 for the Neonatal Fc Receptor: Biological Consequences

    William F. Dall’ Acqua;Robert M. Woods;E. Sally Ward;Susan R. Palaszynski

  • Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes

    P A Kiener;P Moran-Davis;B M Rankin;A F Wahl

  • Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

    Brandon W Higgs;Zheng Liu;Barbara White;Wei Zhu

  • Soluble Fas Ligand Induces Epithelial Cell Apoptosis in Humans with Acute Lung Injury (ARDS)

    G Matute-Bello;W C Liles;K P Steinberg;P A Kiener

  • Soluble CTLA4 molecules and uses thereof

    Peter S. Linsley;Jeffrey A. Ledbetter;Nitin K. Damle;William Brady

  • Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma

    William W. Busse;Rohit Katial;David Gossage;Suha Sari

  • Anthracycline conjugates having a novel linker and methods for their production

    Robert S. Greenfield;Gary R. Braslawsky;Lee J. Olech;Takushi Kaneko

  • Type I interferon: potential therapeutic target for psoriasis?

    Yihong Yao;Laura Richman;Chris Morehouse;Melissa de los Reyes

  • Neutralization of interferon‐α/β–inducible genes and downstream effect in a phase I trial of an anti–interferon‐α monoclonal antibody in systemic lupus erythematosus

    Yihong Yao;Laura Richman;Brandon W. Higgs;Christopher A. Morehouse

  • Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization

    Herren Wu;David S. Pfarr;Ying Tang;Ling-Ling An

  • A role for tumour necrosis factor-α, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome

    Geoffrey M. Gersuk;Cassandra Beckham;Michael R. Loken;Peter Kiener

  • Differential Induction of Apoptosis by Fas-Fas Ligand Interactions in Human Monocytes and Macrophages

    Peter A. Kiener;Patricia M. Davis;Gary C. Starling;Christopher Mehlin

  • Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis.

    Ronan J. Walsh;Sek Won Kong;Sek Won Kong;Yihong Yao;Bahija Jallal

Frequent Co-Authors

Herren Wu
Herren Wu AstraZeneca (United Kingdom)
Anthony J. Coyle
Anthony J. Coyle Takeda (United States)
Ronald Herbst
Ronald Herbst Biolojic Design
Michael S. Kinch
Michael S. Kinch Washington University in St. Louis
Jeffrey A. Ledbetter
Jeffrey A. Ledbetter University of Washington
Alejandro Aruffo
Alejandro Aruffo Syngenta (United States)
Roland Kolbeck
Roland Kolbeck AstraZeneca (United Kingdom)
Peter Kufer
Peter Kufer Amgen (United States)
W. Conrad Liles
W. Conrad Liles University of Washington
Thomas F. Tedder
Thomas F. Tedder Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens the door to diverse online degrees and professional tracks. Many students pursue advanced education in health and management to expand their career options. For those interested in the business side of healthcare, a degree in healthcare management provides strong leadership and administrative skills for roles in hospitals, clinics, and biotech firms.

If mental health is your passion, accelerated msn psychiatric np programs offer a fast track to becoming a highly qualified mental health nurse practitioner. Biology majors may also find rewarding paths in nutrition and wellness. For example, accelerated dietitian programs help students move quickly into the growing field of dietetics.

For those seeking flexible and affordable options, the cheapest online mba healthcare programs make advanced training in healthcare management more accessible. These alternatives complement a science background and can greatly expand your professional opportunities.

Best Scientists Citing Peter A. Kiener

Trending Scientists

Recently Published Articles